EDI Study

Study / Research

A comprehensive study, led by Dr. DeFronzo, involving 315 diabetic patients followed for 6 years, comparing a triple therapy regimen (Metformin, Exenatide, Pioglitazone) against the ADA's stepwise approach, demonstrating superior outcomes for combination therapy.

Mentioned in 1 video

Videos Mentioning EDI Study

337- Insulin resistance masterclass: The full body impact of metabolic dysfunction, treatment & more

337- Insulin resistance masterclass: The full body impact of metabolic dysfunction, treatment & more

Peter Attia MD

A comprehensive study, led by Dr. DeFronzo, involving 315 diabetic patients followed for 6 years, comparing a triple therapy regimen (Metformin, Exenatide, Pioglitazone) against the ADA's stepwise approach, demonstrating superior outcomes for combination therapy.